Comparative studies of Hyaluronan in marketed ophthalmic products

Optometry and Vision Science

Volumn 91, Issue 1, 2014, Pages 32-38

  Liu, X Michael ^a   Harmon, Patricia S ^a   Maziarz, E Peter ^a   Rah, Marjorie J ^a   Merchea, Mohinder M ^a  

^a BAUSCH AND LOMB   (United States)

Author keywords

biologic benefits; contact lens; eye drop; hyaluronan; hyaluronic acid; lens care solution; molecular weight; ophthalmic applications

Indexed keywords

BIOLOGIC BENEFITS; CARE SOLUTIONS; EYE DROPS; HIGH MOLECULAR WEIGHT; HYALURONAN; LOW MOLECULAR WEIGHT; PACKAGING SOLUTIONS; WEIGHT-AVERAGE MOLECULAR WEIGHT;

COMMERCE; CONTACT LENSES; MOLECULAR WEIGHT; MOLECULAR WEIGHT DISTRIBUTION; ORGANIC ACIDS; SIZE EXCLUSION CHROMATOGRAPHY;

HYALURONIC ACID;

BIOMATERIAL; DRUG; EYE DROPS; HYALURONIC ACID; VISCOSUPPLEMENT;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; GEL CHROMATOGRAPHY; MOLECULAR WEIGHT; MEDICINAL CHEMISTRY;

BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; HYALURONIC ACID; MOLECULAR WEIGHT; OPHTHALMIC SOLUTIONS; PHARMACEUTICAL PREPARATIONS; VISCOSUPPLEMENTS;

EID: 84891854879     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000100     Document Type: Article

References (25)

1. Lerner LE, Schwartz DM, Hwang DG, Howes EL, Stern R. Hyaluronan and CD44 in the human cornea and limbal conjunctiva. Exp Eye Res 1998;67:481-4 (Pubitemid 28552970)
2. Presti D, Scott JE. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994;12:281-8 (Pubitemid 24350570)
3. Yoshida K, Nitatori Y, Uchiyama Y. Localization of glycosaminoglycans and CD44 in the human lacrimal gland. Arch Histol Cytol 1996;59:505-13 (Pubitemid 27066149)
4. Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821-5 (Pubitemid 38725595)
5. Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci 1993;34: 2313-5 (Pubitemid 23191260)
6. Nishida T, Nakamura M, Mishima H, Otori T. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1991;53:753-8
7. Scott JE. Extracellular matrix, supramolecular organisation and shape. J Anat 1995;187(Pt. 2):259-69
8. Szczotka-Flynn LB. Chemical properties of contact lens rewetter. Contact Lens Spectrum 2006;21(4):40-5
9. Nakamura M, Hikida M, Nakano T, Ito S, Hamano T, Kinoshita S. Characterization of water retentive properties of hyaluronan. Cornea 1993;12:433-6 (Pubitemid 23249325)
10. Ali M, Byrne ME. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm Res 2009;26:714-26
11. Fagnola M, Pagani MP, Maffioletti S, Tavazzi S, Papagni A. Hyaluronic acid in hydrophilic contact lenses: spectroscopic investigation of the content and release in solution. Cont Lens Anterior Eye 2009;32:108-12
12. Asari A. Medical applications of hyaluronan. In: Garg HG, Hales CA, eds. Chemistry and Biology of Hyaluronan. Boston: Elsevier; 2004:457-73
13. Van Beek M, Jones L, Sheardown H. Hyaluronic acid containing hydrogels for the reduction of protein adsorption. Biomaterials 2008;29:780-9 (Pubitemid 350266050)
14. Fonn D. Targeting contact lens induced dryness and discomfort: what properties will make lenses more comfortable. Optom Vis Sci 2007;84:279-85 (Pubitemid 46624852)
15. Kikuchi T, Yamada H, Shimmei M. Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cartilage 1996;4:99-110 (Pubitemid 26226434)
16. Pauloin T, Dutot M, Joly F, Warnet JM, Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 2009;15:577-83
17. Pauloin T, Dutot M, Warnet JM, Rat P. In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 2008;34:263-73
18. Guillaumie F, Furrer P, Felt-Baeyens O, Fuhlendorff BL, Nymand S, Westh P, Gurny R, Schwach-Abdellaoui K. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications. J Biomed Mater Res (A) 2010;92:1421-30
19. Hsieh YS, Yang SF, Lue KH, Chu SC, Lu KH. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis. J Orthop Res 2008;26:475-84
20. Huang TL, Hsu HC, Yang KC, Yao CH, Lin FH. Effect of different molecular weight hyaluronans on osteoarthritis-related protein production in fibroblast-like synoviocytes from patients with tibia plateau fracture. J Trauma 2010;68:146-52
21. Harmon PS, Maziarz EP, Liu XM. Detailed characterization of hyaluronan using aqueous size exclusion chromatography with triple detection and multiangle light scattering detection. J Biomed Mater Res B Appl Biomater 2012;100:1955-60
22. Liu XM, Gao W, Maziarz EP, Salamone JC, Duex J, Xia E. Detailed characterization of cationic hydroxyethylcellulose derivatives using aqueous size-exclusion chromatography with on-line triple detection. J Chromatogr A 2006;1104:145-53 (Pubitemid 43099886)
23. Viscotek User's Manual and info@viscotek.com. Houston, TX. 2004
24. Robbins CR. The Chemical and Physical Behavior of Human Hair. New York: Van Nostrand Reinhold Co.; 1979
25. Liu XM, Heiler DJ, Menzel T, Brongo A, Burke SE, Cummins K. Sterile Hyaluronic Acid Solutions. U. S. patent application 20120 295869. Published November 22, 2012.